Balasa Dinverno & Foltz’s Idexx Laboratories IDXX Stock Holding History

Balasa Dinverno & Foltz’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1.01M	Sell	3,108 -62	-2%	-$22.8K	0.06%	125
2022 Q2	$1.11M	Sell	3,170 -523	-14%	-$213K	0.07%	120
2022 Q1	$2.02M	Sell	3,693 -242	-6%	-$127K	0.14%	66
2021 Q4	$2.59M	Sell	3,935 -82	-2%	-$51.5K	0.17%	59
2021 Q3	$2.5M	Sell	4,017 -585	-13%	-$393K	0.17%	58
2021 Q2	$2.91M	Sell	4,602 -127	-3%	-$70.1K	0.21%	47
2021 Q1	$2.31M	Buy	4,729 +394	+9%	+$197K	0.19%	53
2020 Q4	$2.17M	Buy	4,335 +262	+6%	+$117K	0.18%	51
2020 Q3	$1.6M	Buy	+4,073	New	+$1.51M	0.15%	64

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Balasa Dinverno & Foltz's IDXX Position: Q3 2022 in Review

Balasa Dinverno & Foltz reduced its Idexx Laboratories (IDXX) stake by 2% in Q3 2022, selling an estimated $22.8K and leaving 3,108 shares worth $1.01M. The position accounts for 0.06% of the portfolio, ranked #125.

Balasa Dinverno & Foltz first reported a position in IDXX in Q3 2020 and has held it in 9 quarters since. The position peaked at $2.91M in Q2 2021. 924 funds tracked by Wall St. Rank hold IDXX as of Q3 2022.

Balasa Dinverno & Foltz held 3,108 shares of Idexx Laboratories worth $1.01M as of Q3 2022.
Balasa Dinverno & Foltz sold 62 Idexx Laboratories shares in Q3 2022, an estimated $22.8K.
Idexx Laboratories made up 0.06% of Balasa Dinverno & Foltz's portfolio in Q3 2022, its #125 holding.
Balasa Dinverno & Foltz first reported a position in Idexx Laboratories in Q3 2020 and has held it in 9 quarters since.
Balasa Dinverno & Foltz's Idexx Laboratories position peaked at $2.91M in Q2 2021.
924 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2022.

Based on Balasa Dinverno & Foltz's 13F filing for Q3 2022, filed 25 Oct 2022.